TBPH Theravance Biopharma, Inc.

NASDAQ
$17.02

Theravance Biopharma, Inc. (TBPH) SEC Filings

Everything TBPH has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

46 filings
Date Form Filing
8-K Acquisition Disposition
144
8-K Acquisition Disposition · Other Event
8-K Investor Presentation · Other Event · Other Reg Fd
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4/A
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.